Support the news

Boutique Biotech Firms Try To Compete With Big Pharma27:13
Download

Play
This article is more than 8 years old.
Labs for hire, like those at Charles River Laboratories in Wilmington, have enabled small drug companies to move their ideas through the drug approval process. (Curt Nickisch/WBUR)
Labs for hire, like those at Charles River Laboratories in Wilmington, have enabled small drug companies to move their ideas through the drug approval process. (Curt Nickisch/WBUR)

The face of the pharmaceutical sector has for a long time been that of Big Pharma. But in Boston, biotech now includes small, boutique firms with just a few employees — even just one employee — focused on just one or two treatment lines. We take a look at the changing landscape of biotech firms.

Guests:

  • Michael Gilman, founder and CEO, Stromedix
  • Scott Kirsner, innovation columnist, Boston Globe
  • Curt Nickish, business and technology reporter, WBUR

More:

This segment aired on May 31, 2011.

+Join the discussion
TwitterfacebookEmail

Support the news